Compare Moderna, Inc. (MRNA) vs Snap Inc (SNAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Snap Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Snap Inc trades at $4.57 (market cap $7.67B). The key difference: Moderna, Inc. is far larger — about 3.1× Snap Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Snap Inc nearer its low. Which is the better fit depends on your goals.
| MRNA | SNAP | |
|---|---|---|
Market Cap | $23.60B | $7.67B |
Sector | Health | Media |
52-Week High | $81.80 | $10.35 |
52-Week Low | $22.36 | $3.93 |
Enterprise Value | $19.70B | $9.05B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →
